Navigation Links
Pharmacopeia Announces Third Quarter 2007 Financial Results
Date:11/1/2007

0%. General and administrative expense was $8.0 million for the nine months ended September 30, 2007, compared to $7.0 million for the same period in 2006, an increase of 15%. These increases were largely due to higher consulting and recruiting costs.

Pharmacopeia reported a net loss of $11.7 million, or $0.40 per basic and diluted share, for the quarter ended September 30, 2007. The company recorded a net loss of $4.7 million, or $0.31 per basic and diluted share, for the same quarter in 2006. For the nine months ended September 30, 2007, Pharmacopeia recorded a net loss of $28.6 million, or $1.07 per basic and diluted share. Pharmacopeia recorded a net loss of $19.6 million, or $1.28 per basic and diluted share for the 2006 nine-month period.

Further details regarding Pharmacopeia's third quarter 2007 results will be presented in a conference call today, November 1, 2007, at 5:00 p.m. Eastern time. Dr. Leslie J. Browne, President and Chief Executive Officer, Mr. Brian M. Posner, Executive Vice President and Chief Financial Officer, and Dr. Rene Belder, Vice President, Clinical and Regulatory Affairs, will host the call. Forward-looking and material information may be discussed on this conference call.

Date: November 1, 2007

Time: 5:00 p.m. EDT

Domestic Callers: (800) 890-0881

International Callers: (719) 325-2379

Confirmation Code: 9745493 Name of Conference: Pharmacopeia's Third Quarter 2007 Financial Results

Webcast information can be accessed by visiting http://www.pharmacopeia.com

A replay of the conference call can be accessed by dialing toll-free (888) 203-1112 in the U.S., or (719) 457-0820 outside the U.S. The access code for the replay is 9745493. A replay of the webcast will also be accessible on Pharmacopeia's website on the "Investors" p
'/>"/>

SOURCE Pharmacopeia
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Pharmacopeia Announces Positive Results from Initial DARA Clinical Trial
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Sygnis Pharma AG announces date for presentation of clinical results
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... , Sept. 2, 2014  PANTHERx Specialty ... Specialty Pharmacy Accreditation from URAC, a ... that establishes quality standards for the health care ... The URAC accreditation process demonstrates ... a framework to improve business processes through benchmarking ...
(Date:9/2/2014)... Calif. , Sept. 2, 2014  Based ... tumor treatment device market, Frost & Sullivan recognizes ... Frost & Sullivan Award for Technology Innovation Leadership. ... breast fibroadenoma and malignant tumors with its proprietary ... tool is a reliable, accurate, and easy-to-control ultrasound-guided ...
(Date:9/2/2014)... Mast Therapeutics, Inc . (NYSE MKT: MSTX) today announced that the ... at the Rodman and Renshaw 16 th Annual Global Investment ... in the Holmes II Salon at The New York Palace Hotel ... parties can access a live audio webcast and slide presentation on ... presentation will be available on the web site for 30 days. ...
Breaking Medicine Technology:PANTHERx Specialty Pharmacy Applying for URAC Specialty Pharmacy Accreditation 2Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 2Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 3Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 4Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 5Mast Therapeutics To Present At The Rodman And Renshaw 16th Annual Global Investment Conference On September 9th 2Mast Therapeutics To Present At The Rodman And Renshaw 16th Annual Global Investment Conference On September 9th 3
(Date:9/2/2014)... in Spanish . ... an experiment conducted on rats, that hyperproteic diets could be ... groups with bone disease problems, such as the elderly or ... proteinin the case of the present study, soy proteinis preferable ... increased the level of calcium in bones by as much ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 According ... http://www.idataresearch.com ), the leading global authority in medical ... market is expected to grow to over ... by an increase in the number of procedures ... kidney stones. This market includes TURP devices, laser ...
(Date:9/2/2014)... Splashtop Inc. , the worldwide leader ... NTT DoCoMo to deliver Splashtop Business Lite for ... is included in NTT DoCoMo’s “Business Plus” program. , ... empower users to remote access their corporate computers from ... million users worldwide. Splashtop delivers the best in ...
(Date:9/2/2014)... Medical Goods manufacture ThermoTek , announced today a ... Inc. to help customers acquire capital goods faster and ... finance shopping platform has enabled businesses to quickly and ... business. , Said LeaseQ Vice President Cory Damm, ... to provide customers faster access to capital and allow ...
(Date:9/2/2014)... September 02, 2014 Based on ... used during hysterectomy, kidney and spleen surgeries, have ... cells and harm patients. , An article ... Michael A. Seidman, Titilope Oduyebo and Bradley J. ... Mesenchymal Neoplasms" published on Nov 26, 2012 defines ...
Breaking Medicine News(10 mins):Health News:Study conducted on rats suggests that hyperproteic diets can be beneficial for bones 2Health News:European Urological Device Market Is Expected to Grow to over €2 billion by 2020: Led by Coloplast, Wellspect HealthCare, Teleflex, C. R. Bard and Olympus 2Health News:European Urological Device Market Is Expected to Grow to over €2 billion by 2020: Led by Coloplast, Wellspect HealthCare, Teleflex, C. R. Bard and Olympus 3Health News:Splashtop and NTT DoCoMo Partner to Deliver “Splashtop Business Lite” Secure Remote Access Solution to Business Customers 2Health News:Medical Technology Manufacturer ThermoTek Announces New Partnership with LeaseQ.com to Help More Customers Acquire Equipment Faster and Cheaper 2Health News:New York Law Firm Discusses Allegedly Dangerous Surgical Morcellator Devices And Cancer Risk 2Health News:New York Law Firm Discusses Allegedly Dangerous Surgical Morcellator Devices And Cancer Risk 3
... HealthDay Reporter , TUESDAY, Aug. 24 (HealthDay News) -- ... by a U.S. judge to halt any expansion ... temporary injunction, which basically blindsided the scientific community, effectively ... days. That was when then-President Bush ordered that federal ...
... people lose weight and body fat when they exercise and eat ... (MR) spectroscopy can provide the answer and help predict who ... online and will appear in the November issue of the journal ... the same and have the same body mass index (BMI), but ...
... HealthDay Reporter , TUESDAY, Aug. 24 (HealthDay News) -- ... a day boost a woman,s odds of premature delivery? ... The researchers looked at the soft drink habits of ... from 1996 to 2002. The investigators found a link ...
... 2010 The Joint Commission has certified UT Southwestern ... Center, a distinction for hospitals fostering specialized stroke care ... imaging specialists, nurses and technicians have ready access to ... or after a stroke. Each year about 700,000 people ...
... breast imaging exams may increase a woman,s risk of ... online and in the October issue of Radiology ... are very low. "A single breast-specific gamma imaging ... lifetime risk of inducing fatal cancer greater than or ...
... 2010) While success is surely sweeter than failure, it ... fail spectacularly often flourish more in the long run, ... of management at the University of Colorado Denver Business School. ... Journal , focused on companies and organizations that launch satellites, ...
Cached Medicine News:Health News:Scientists Dismayed by Stem Cell Research Ruling 2Health News:Scientists Dismayed by Stem Cell Research Ruling 3Health News:Fat distribution plays a role in weight loss success in patients at risk of diabetes 2Health News:Study Suggests Link Between Diet Sodas, Preterm Delivery 2Health News:Study Suggests Link Between Diet Sodas, Preterm Delivery 3Health News:UT Southwestern University Hospital -- St. Paul recognized as Primary Stroke Center 2Health News:UT Southwestern University Hospital -- St. Paul recognized as Primary Stroke Center 3Health News:New nuclear breast imaging technologies associated with higher cancer risks 2Health News:New nuclear breast imaging technologies associated with higher cancer risks 3Health News:University of Colorado Denver Business School study shows failure better teacher than success 2
Rapid reagent impregnated disk test for presumptive identification of Candida albicans....
... Electronic Medical Records for small and large ... from check-in to check-out. Review the complete ... medications, to allergies, labs and charts all ... your patient records immediately. Communicate electronically with ...
... Written specifically for urologists by ... utilizes touch screen technology to ... eliminate the use of a ... makes using an EMR faster ...
... a new generation of advanced Electronic Medical ... the largest, numerically codified medical vocabularies in ... data elements embedded in MedcomSoft Record, healthcare ... an easy and intuitive point and click ...
Medicine Products: